These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29122566)

  • 1. Mutations of candidate tumor suppressor genes at chromosome 3p in intrahepatic cholangiocarcinoma.
    You HL; Huang WT; Liu TT; Weng SW; Eng HL
    Exp Mol Pathol; 2017 Dec; 103(3):249-254. PubMed ID: 29122566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
    Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
    Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos.
    Brandi G; Deserti M; Palloni A; Turchetti D; Zuntini R; Pedica F; Frega G; De Lorenzo S; Abbati F; Rizzo A; Di Marco M; Massari F; Tavolari S
    Cancer Genet; 2020 Oct; 248-249():57-62. PubMed ID: 33093002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.
    Lowery MA; Ptashkin R; Jordan E; Berger MF; Zehir A; Capanu M; Kemeny NE; O'Reilly EM; El-Dika I; Jarnagin WR; Harding JJ; D'Angelica MI; Cercek A; Hechtman JF; Solit DB; Schultz N; Hyman DM; Klimstra DS; Saltz LB; Abou-Alfa GK
    Clin Cancer Res; 2018 Sep; 24(17):4154-4161. PubMed ID: 29848569
    [No Abstract]   [Full Text] [Related]  

  • 5. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.
    Jiang G; Zhang W; Wang T; Ding S; Shi X; Zhang S; Shi W; Liu A; Zheng S
    Jpn J Clin Oncol; 2020 Sep; 50(10):1117-1125. PubMed ID: 32533190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers.
    Liao H; Chen X; Wang H; Lin Y; Chen L; Yuan K; Liao M; Jiang H; Peng J; Wu Z; Huang J; Li J; Zeng Y
    Cancer Res; 2024 Jun; 84(11):1747-1763. PubMed ID: 38471085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.
    Wong N; Li L; Tsang K; Lai PB; To KF; Johnson PJ
    J Hepatol; 2002 Nov; 37(5):633-9. PubMed ID: 12399230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay.
    Arnold A; Bahra M; Lenze D; Bradtmöller M; Guse K; Gehlhaar C; Bläker H; Heppner FL; Koch A
    Exp Mol Pathol; 2015 Oct; 99(2):344-53. PubMed ID: 26260902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
    Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma.
    Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A
    Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
    Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
    Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
    Carapeto F; Bozorgui B; Shroff RT; Chagani S; Solis Soto L; Foo WC; Wistuba I; Meric-Bernstam F; Shalaby A; Javle M; Korkut A; Kwong LN
    Hepatology; 2022 Feb; 75(2):297-308. PubMed ID: 34510503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.
    Jiao Y; Pawlik TM; Anders RA; Selaru FM; Streppel MM; Lucas DJ; Niknafs N; Guthrie VB; Maitra A; Argani P; Offerhaus GJA; Roa JC; Roberts LR; Gores GJ; Popescu I; Alexandrescu ST; Dima S; Fassan M; Simbolo M; Mafficini A; Capelli P; Lawlor RT; Ruzzenente A; Guglielmi A; Tortora G; de Braud F; Scarpa A; Jarnagin W; Klimstra D; Karchin R; Velculescu VE; Hruban RH; Vogelstein B; Kinzler KW; Papadopoulos N; Wood LD
    Nat Genet; 2013 Dec; 45(12):1470-1473. PubMed ID: 24185509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.